Biosimilars Pipeline

Biosimilars is a Biologic therapeutic item which is duplicate of a unique item that is made by an alternate organization. Biosimilars are formally affirmed creative adaptations of unique items, and can be made when the first item's patent terminates. Reference to the innovator product is an integral component of the approval. This session also finds place for all the biosimilars exhibitors associated with the field of biosimilars and biologics. Biosimilars innovative products are on the rise.

  • Economic Aspects Towards Biosimilars
  • Cost and Risk Management
  • Global Impact of Biosimilars Over Generics
  • Monitoring the Production of Biological Products